-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mitapivat Sulfate in Alpha Thalassaemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mitapivat Sulfate in Alpha Thalassaemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mitapivat Sulfate in Alpha Thalassaemia Drug Details: Mitapivat sulfate (Pyrukynd)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mitapivat Sulfate in Beta Thalassaemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mitapivat Sulfate in Beta Thalassaemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mitapivat Sulfate in Beta Thalassaemia Drug Details: Mitapivat sulfate (Pyrukynd)...
-
Company Insights
NewKaligia Biosciences LLC Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our Kaligia Biosciences LLC Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. Kaligia Biosciences LLC specializes in the development of non-invasive medical monitoring devices. The company focuses on the utilization of advanced light wave technology to create innovative biosensors to replace traditional, invasive body parameter testing methods, providing faster and more accurate results. It is headquartered in Largo, Florida, the US. GlobalData's Medical Devices company profile report, “Kaligia Biosciences LLC Pipeline...
-
Product Insights
NewSpectral MD Holdings Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Spectral MD Holdings Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Spectral MD Holdings Ltd develops technology through predictive analytics and AI algorithms that enables clinicians make accurate and faster treatment decisions. The company is headquartered in Dallas, Texas, the US. GlobalData's Medical Devices company profile report, “Spectral MD Holdings Ltd Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products....
-
Product Insights
NewNanomix Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Nanomix Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Nanomix Inc (Nanomix) is a medical device company that develops analytical detection devices for the point of care diagnostics. The company provides Nanomix system which is an automated system consisting of a handheld reader and self-contained assay cartridge with a carbon nanotube biosensor. It also offers Nanomix eLab, a point of care testing solution for use in emergency departments and...
-
Product Insights
NewSpinChip Diagnostics AS Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our SpinChip Diagnostics AS Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. SpinChip Diagnostics AS (SpinChip) is a diagnostics company that develops next-generation point-of-care platforms for in vitro diagnostics. The products include SpinChip platform, All-in-one Analyzer and Cartridge. The SpinChip Analyzer is a fully automated processing software equipped with mechatronics, optics, user interfaces, electronics and connectivity features. The company develops and delivers Point Of Care Platform for immediate clinical decisions and...
-
Product Insights
Likelihood of Approval Analysis for Warts
Overview How likely is it that the drugs in Warts will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Warts Overview Warts, caused by the human papillomavirus (HPV), are common skin growths...
-
Product Insights
Likelihood of Approval Analysis for Paraganglioma (Glomus Jugulare Tumor)
Overview How likely is it that the drugs in Paraganglioma (Glomus Jugulare Tumor) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Paraganglioma (Glomus Jugulare Tumor) Overview Abnormal growth of chromaffin cells,...
-
Product Insights
Likelihood of Approval Analysis for Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Overview How likely is it that the drugs in Coronary Artery Disease (CAD) (Ischemic Heart Disease) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Coronary Artery Disease (CAD) (Ischemic Heart Disease)...